Company Data
Salarius Pharmaceuticals
Ticker
SLRX
Current Price
$5.68 -4.54%
Market Cap
$2.9M
Price Target
Refer to Report
Volume
91.3K
52wk Range
$4.76 - $108
Overview
Salarius Pharmaceuticals Inc is a biotechnology company developing targeted therapies to treat pediatric and other cancers, including advanced solid tumors. Its lead compound Seclidemstat is in clinical development for treating Ewing sarcoma.